Accounts Payable and Accrued Liabilities Disclosure [Text Block] |
7.
|
Accounts payable and Accrued Liabilities
|
|
|
Accounts Payable
|
|
|
|
Accrued Liabilities
|
|
|
|
June 30,
2025
|
|
|
December 31,
2024
|
|
|
|
June 30,
2025
|
|
|
December 31,
2024
|
|
Current accounts payable
|
|
$ |
533,763 |
|
|
$ |
484,934 |
|
Accrued liabilities
|
|
$ |
309,332 |
|
|
$ |
322,548 |
|
Deferred accounts payable
|
|
|
1,179,647 |
|
|
|
1,039,304 |
|
Deferred Compensation to Directors (a)
|
|
|
1,891,120 |
|
|
|
1,723,048 |
|
Total
|
|
$ |
1,713,410 |
|
|
$ |
1,524,238 |
|
Total
|
|
$ |
2,200,452 |
|
|
$ |
2,045,596 |
|
|
(a)
|
The director fees and interest accrued under the deferred Compensation Plan where most directors elected to defer 100% of their fees for 2025, 2024, 2023, 2022, 2021 and 2020 excluding Jan Loeb who was nominated to the Board on July 28, 2023, and elected to a three-year term at the annual shareholder meeting on October 12, 2023. This amount also includes the deferred compensation of a former Board advisor per an agreement to defer payments due under an advisor agreement and two previous Board members.
|
|